For U.S. Residents Only
ABOUT ELIGARD
A Hormonal Therapy for
Advanced Prostate Cancer
ELIGARD - A Hormonal Therapy for Prostate Cancer
ELIGARD is a prescription medication for the palliative treatment (management of
symptoms) of advanced prostate cancer. ELIGARD is an LHRH (luteinizing hormone-releasing
hormone) agonist. It is designed to reduce the amount of testosterone in the body
by reducing the testicles' production of testosterone. It is not a cure for advanced
prostate cancer.
ELIGARD is now available in 4 different prescription doses, giving you and your
physician flexible dosing options for treating your advanced prostate cancer. The
ELIGARD 45 mg shot, the newest addition to the ELIGARD family, is the first and
only 6-month hormone therapy for the treatment of advanced prostate cancer. ELIGARD
45 mg gives you the benefit of a full year of hormone therapy with just 2 injections.
Ask you doctor about twice-yearly ELIGARD.
How It Works on Advanced Prostate Cancer
ELIGARD is an LHRH agonist. Male hormones, such as testosterone, stimulate the growth
of prostate cancer cells. The goal of hormonal therapy for advanced prostate cancer
is to lower the body's level of male hormones and thereby shrink or slow down the
growth of prostate tumors. Most of the body's testosterone is made by the testicles;
ELIGARD prevents the testicles from producing testosterone.
As with other LHRH agonists, the first shot of ELIGARD will make testosterone levels
rise temporarily. However, within 2 to 4 weeks, the ELIGARD shot causes testosterone
levels to fall. In most cases, the level of testosterone that results from ELIGARD
is the same level or lower than that achieved by surgical castration.
- How often will I get an ELIGARD injection?
- How long might my treatment last?
- Who will give me the shot?
- Where will the shot be given?
- What are the common side effects of ELIGARD?
- What should I do if they occur?
- How does the "palpable mass" feel?
- Which medications should I avoid while I'm taking
ELIGARD?
- What should I not do while on ELIGARD?
If you are taking hormonal therapy, are you bothered by hot flashes?
|
yes, often 0% |
|
no 0% |
|
sometimes 0% |
Indication
ELIGARD is a prescription drug, given by injection, for the management of advanced
prostate cancer. However, there is no known cure for prostate cancer.
Important Safety Information
ELIGARD should not be used by women, children, or anyone who is allergic to the
drug leuprolide acetate or any of the ingredients of ELIGARD.
ELIGARD, like other drugs in its class, causes a temporary increase in testosterone
during the first week of treatment. Patients may experience worsening of symptoms
or new symptoms during the first weeks of treatment, including bone pain, nerve
damage, blood in the urine, or difficulty urinating. The most common side effects
are hot flashes, injection site pain (including burning and stinging), fatigue,
and testicular atrophy.
Please see and full mixing and administration instructions.
Click here
for information on drug anti-counterfeiting.
| |
| |
| | | | |